Evidence map›Paper›PMID 34580063›Full record

ArticleCancer research2021

Elimination of Radiation-Induced Senescence in the Brain Tumor Microenvironment Attenuates Glioblastoma Recurrence.

Eliot Fletcher-Sananikone, Suman Kanji, Nozomi Tomimatsu, Luis Fernando Macedo Di Cristofaro, Rahul K Kollipara, Debabrata Saha, John R Floyd, Patrick Sung, Robert Hromas, Terry C Burns and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 130 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
130citing papers in PubMed, 1 pooled it
16.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

130 citing papers in PubMed, 1 synthesis or guideline pooled it, 186 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Mechanisms, Microenvironments, and Models: Understanding Therapeutic Resistance in Glioblastoma.International journal of radiation oncology, biology, physics · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

70 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Eliot Fletcher-Sananikone *Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas.
Suman Kanji *Department of Neurosurgery, University of Texas Health, San Antonio, Texas.
Nozomi TomimatsuDepartment of Neurosurgery, University of Texas Health, San Antonio, Texas.
Luis Fernando Macedo Di CristofaroSchool of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, Brazil.ORCID https://orcid.org/0000-0001-9856-2308
Rahul K KolliparaEugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, Texas.
Debabrata SahaDepartment of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas.ORCID https://orcid.org/0000-0003-3477-4111
John R FloydDepartment of Neurosurgery, University of Texas Health, San Antonio, Texas.
Patrick SungDepartment of Biochemistry and Structural Biology, University of Texas Health, San Antonio, Texas.
Robert HromasDepartment of Medicine, University of Texas Health, San Antonio, Texas.
Terry C BurnsDepartment of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota.
Ralf KittlerEugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, Texas.ORCID https://orcid.org/0000-0002-0098-6792
Amyn A HabibDepartment of Neurology, University of Texas Southwestern Medical Center, Dallas, Texas.
Bipasha MukherjeeDepartment of Neurosurgery, University of Texas Health, San Antonio, Texas.
Sandeep BurmaDepartment of Neurosurgery, University of Texas Health, San Antonio, Texas. burma@uthscsa.edu.
The University of Texas Health Science Center at San Antonio · USSouthwestern Medical Center · USThe University of Texas Southwestern Medical Center · USCentro Universitário de Araraquara · BRMayo Clinic · USVA North Texas Health Care System · US

Funding

Mechanisms of DNA Homology-directed Genome Repair and Tumor SuppressionR35CA241801 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI SUNG, PATRICK · 2019 to 2025
$6.0M
Enhancing MAPK-targeted Therapy in PDX Models of BRAF-Mutant Pediatric Brain TumorsR01CA258381 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI BURMA, SANDEEP · 2021 to 2025
$2.8M
The role of Nrf2 in mediating resistance to EGFR inhibition in glioblastomaR01CA244212 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI HABIB, AMYN · 2020 to 2024
$1.9M
Radiation-induced senescence in the brain microenvironment: Implications for glioblastoma recurrence and therapyR01CA246807 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI BURMA, SANDEEP · 2021 to 2025
$1.8M
Molecular mechanisms of GBM radioresistance and strategies for radiosensitizationR01CA149461 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI BURMA, SANDEEP · 2011 to 2015
$1.6M
Mechanisms of EXO1 regulation in response to radiation-induced DNA damageR01CA197796 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI BURMA, SANDEEP · 2016 to 2020
$1.6M
BLRD VA I01 BX002559NCI NIH HHS R01 CA197796NCI NIH HHS R01 CA244212NCI NIH HHS R01 CA246807NCI NIH HHS R01 CA258381NCI NIH HHS R35 CA241801
6 · The paper itself

Abstract

Glioblastomas (GBM) are routinely treated with ionizing radiation (IR) but inevitably recur and develop therapy resistance. During treatment, the tissue surrounding tumors is also irradiated. IR potently induces senescence, and senescent stromal cells can promote the growth of neighboring tumor cells by secreting factors that create a senescence-associated secretory phenotype (SASP). Here, we carried out transcriptomic and tumorigenicity analyses in irradiated mouse brains to elucidate how radiotherapy-induced senescence of non-neoplastic brain cells promotes tumor growth. Following cranial irradiation, widespread senescence in the brain occurred, with the astrocytic population being particularly susceptible. Irradiated brains showed an altered transcriptomic profile characterized by upregulation of CDKN1A (p21), a key enforcer of senescence, and several SASP factors, including HGF, the ligand of the receptor tyrosine kinase (RTK) Met. Preirradiation of mouse brains increased Met-driven growth and invasiveness of orthotopically implanted glioma cells. Importantly, irradiated p21

Indexed as

Cellular SenescenceSenescence-Associated Secretory PhenotypeTumor MicroenvironmentAniline CompoundsAnimalsAntineoplastic AgentsAstrocytesBrainGamma RaysGlioblastomaHumansMiceMice, Inbred BALB CMice, Inbred C57BLNeoplasm Recurrence, LocalSulfonamidesAniline CompoundsAntineoplastic AgentsnavitoclaxSulfonamides

Identifiers

PMID34580063
PMCPMC9724593
OpenAlexW3202117617

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.